Optimising workflows

We provide solutions for customers working across cell line development:

Novel Biotherapeutics

Isolate, screen and characterise attributes for clones producing novel recombinant proteins e.g. monoclonal antibodies or therapeutic proteins for rare diseases

Read More >

Biosimilars and Biobetters

Generate stable cell lines to create equivalents (Biosimilars) or improved versions (Biobetters) of existing blockbuster therapeutic antibodies for which the patent has, or will shortly, expire

Read More >

Gene Therapy

Develop new, stable, producer cell lines manufacturing viruses to subsequently infect target cells of patients

Read More >

Gene Editing & Cell Engineering

Optimise your drug discovery process using targeted gene editing to create stable cell lines as cellular reagents, for use in target validation, functional genomics and disease modelling

Read More >


"How a Top-5 Pharma Doubled the Speed of Cell Line Development"

Latest News

Viral Production for Gene Therapy

Moving towards clinical grade production In the latest edition of this Podcast series, Duncan Borthwick speaks to Mark Stockdale about the developing regulatory landscape around viral production for clinical gene

Cell Line Development – A look at the evolution, new advances and future developments of this critical process step

In a recent interview with Cell Culture Dish, Dr Ian Taylor discusses the evolution of cell line development, new advances in technologies and workflows, and future advances. The discussion includes

Podcast | Planning a CLD Lab

Workflows, Clonality Assurance and New Tech Following the postponement of the BioProcess International (BPI) US West Conference, Santa Clara in March 2020,  Duncan Borthwick speaks to Mark Stockdale about the

Solentim names Mark Truesdale as new CEO

Dr Mark Truesdale Bournemouth, UK, 2nd March 2020 / Sciad Newswire / Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed

Join Solentim, along with leading European cell line development innovators, at Bioprocessing Summit Europe 2020

Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be exhibiting at the 3rd annual Bioprocessing Summit Europe, taking place 24-26 March 2020 in

Join Solentim in meeting Europe’s leading innovators at Biologics World Nordic

Nordic region comes out top in the annual European Innovation Scoreboard (EIS) which provides a comparative assessment of research and innovation performance across the EU Life